Patent office issues notice of allowance to InSite for DuraSite 2

InSite Vision received a notice of allowance from the U.S. Patent and Trademark Office for its DuraSite 2 drug delivery system, according to a news release.The patent should provide protection for the DuraSite 2 sustained delivery technology and drugs formulated with it through 2029, the release said.

Full Story →